Search for: All records

Mechanical deformation of polymer networks causes molecular-level motion and bond scission that ultimately lead to material failure. Mitigating this strain-induced loss in mechanical integrity is a significant challenge, especially in the development of active and shape-memory materials. We report the additive manufacturing of mechanical metamaterials made with a protein-based polymer that undergo a unique stiffening and strengthening behavior after shape recovery cycles. We utilize a bovine serum albumin-based polymer and show that cyclic tension and recovery experiments on the neat resin lead to a ~60% increase in the strength and stiffness of the material. This is attributed to the release of stored length in the protein mechanophores during plastic deformation that is preserved after the recovery cycle, thereby leading to a “strain learning” behavior. We perform compression experiments on three-dimensionally printed lattice metamaterials made from this protein-based polymer and find that, in certain lattices, the strain learning effect is not only preserved but amplified, causing up to a 2.5× increase in the stiffness of the recovered metamaterial. These protein–polymer strain learning metamaterials offer a unique platform for materials that can autonomously remodel after being deformed, mimicking the remodeling processes that occur in natural materials. 

Globally, traumatic injury is a leading cause of suffering and death. The ability to curtail damage and ensure survival after major injury requires a time‐sensitive response balancing organ perfusion, blood loss, and portability, underscoring the need for novel therapies for the prehospital environment. Currently, there are few options available for damage control resuscitation (DCR) of trauma victims. We hypothesize that synthetic polymers, which are tunable, portable, and stable under austere conditions, can be developed as effective injectable therapies for trauma medicine. In this work, we design injectable polymers for use as low volume resuscitants (LVRs). Using RAFT polymerization, we evaluate the effect of polymer size, architecture, and chemical composition upon both blood coagulation and resuscitation in a rat hemorrhagic shock model. Our therapy is evaluated against a clinically used colloid resuscitant, Hextend. We demonstrate that a radiant star poly(glycerol monomethacrylate) polymer did not interfere with coagulation while successfully correcting metabolic deficit and resuscitating animals from hemorrhagic shock to the desired mean arterial pressure range for DCR – correcting a 60% total blood volume (TBV) loss when given at only 10% TBV. This highly portable and non‐coagulopathic resuscitant has profound potential for application in trauma medicine.